cpi 1189 has been researched along with AIDS Dementia Complex in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clifford, DB; Cohen, BA; Ellis, RJ; Kieburtz, K; Letendre, S; Marder, K; Marra, CM; McArthur, JC; McDermott, MP; Schifitto, G | 1 |
Arendash, GW; Bjugstad, KB; Flitter, WD; Garland, WA; Kirstein, CL; Philpot, RM | 1 |
Flitter, WD; Garland, WA; Irwin, I; Kusdra, L; Pulliam, L; Rempel, H | 1 |
1 trial(s) available for cpi 1189 and AIDS Dementia Complex
Article | Year |
---|---|
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
Topics: Adult; AIDS Dementia Complex; Antioxidants; Biomarkers; Butanes; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Nitrogen Oxides; Patient Compliance; Psychometrics; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
2 other study(ies) available for cpi 1189 and AIDS Dementia Complex
Article | Year |
---|---|
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
Topics: Administration, Oral; AIDS Dementia Complex; Animals; Antioxidants; Apoptosis; Astrocytes; Basal Ganglia; Blood-Brain Barrier; Butanes; Corpus Callosum; Depression, Chemical; Disease Models, Animal; Drug Evaluation, Preclinical; Glial Fibrillary Acidic Protein; Gliosis; Hydroxyl Radical; Immunoglobulin G; Injections, Intraventricular; Lipid Peroxidation; Male; Neocortex; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Sprague-Dawley; Salicylates; Septum Pellucidum; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2000 |
CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation.
Topics: AIDS Dementia Complex; Apoptosis; Brain; Butanes; Cells, Cultured; Culture Media, Conditioned; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HIV Envelope Protein gp120; Humans; Macrophages; Mitogen-Activated Protein Kinases; Monocytes; Necrosis; Neurons; Neurotoxins; NF-kappa B; Nitrogen Oxides; Phosphorylation; Protein Transport; Quinolinic Acid; Tumor Necrosis Factor-alpha | 2001 |